Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Hong Kong formally approves Fosun-BioNTech vaccine

01/25/2021 | 04:51am EDT

HONG KONG, Jan 25 (Reuters) - Hong Kong has formally approved use of the Fosun-BioNTech vaccine, the city government said on Monday, marking the first COVID-19 vaccine accepted in the Asian financial hub.

The move comes as Hong Kong has lagged other developed cities in rolling out vaccines and with mainland China having started its vaccine program in July last year. (Reporting by Twinnie Siu and Donny Kwok; Writing by Farah Master; Editing by Louise Heavens)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.11% 8268 Delayed Quote.12.89%
BIONTECH SE 5.04% 328.35 Delayed Quote.302.78%
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 9.54% 81.88 End-of-day quote.51.66%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
All news about SINOVAC BIOTECH LTD.
07/27SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
RE
07/26SINOVAC BIOTECH : Brazil says China's Sinopharm seeks COVID-19 vaccine emergency..
RE
07/26SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
RE
07/24SINOVAC BIOTECH : Indonesia prepares more ICU units, waits to see if COVID curbs..
RE
07/23SINOVAC BIOTECH : China's Sinovac evaluates vaccine plant in Chile
RE
07/20SINOVAC BIOTECH : Receives Approval on Sabin Strain Based Inactivated Polio Vacc..
PU
07/20SINOVAC BIOTECH : CoronaVac Used on Child Population in China, Good Antibody Lev..
PU
07/20SINOVAC Biotech Ltd. Announces Use of CoronaVac, its COVID-19 Vaccine on Chil..
CI
07/19SINOVAC BIOTECH : Polio Vaccine Gets China's Medical Regulator OK
MT
07/19SINOVAC BIOTECH : Receives Approval on Sabin Strain Based Inactivated Polio Vacc..
BU
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,1%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | SVA | AGP8696W1045 | MarketScreener
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED2.02%96 600
WUXI BIOLOGICS (CAYMAN) INC.15.27%64 616
SAMSUNG BIOLOGICS CO.,LTD.7.75%51 119
BIOGEN INC.33.44%48 694
ALEXION PHARMACEUTICALS, INC.0.00%40 336